CEPU Q4 2024 Earnings Steep Loss Shocks Market as Adjusted Earnings Miss by Over 164 GIB Q1 2026 Earnings EPS Misses Estimates Amid Disciplined Execution CLDT Q1 2026 Earnings EPS Surpasses Expectations Narrowing Loss REVB Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Reports Operating Loss ITGR Q1 2026 Earnings Slight EPS Miss Amid Operational Execution PFLT Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Falls Short